Known as GLP-1 (glucagon-like peptide-1) agonists, this class of medications mimics a natural hormone the small intestine releases after you eat
Lifestyle Changes to Support Smooth Discontinuation Some research indicates that the medication might cause weight gain in some individuals, while others may experience weight loss or no change at all
This can be due to reduced calorie intake, changes in metabolism, or mild dehydration from side effects like nausea
Theyll utilize real-world electronic health records, machine learning, and other novel methods to investigate changes in obesity-related healthcare usage before and after the emergence of these medications, as well as identify predictors of GLP-1-assisted weight loss, the drugs effectiveness by subpopulation, and how these rapidly evolving therapies may influence future life expectancy based on policy changes that address the existing disparities in access and use.
Positive regulation of A-RAF by phosphorylation of isoform-specific hinge segment and identification of novel phosphorylation sites
Your provider will adjust based on how you feel and any lab guidance